Harbour Investments’s Microbot Medical MBOT Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$129 Buy
66
+65
+6,500% +$133 ﹤0.01% 4587
2026
Q1
$2 Hold
1
﹤0.01% 4657
2025
Q4
$2 Buy
+1
New +$2 ﹤0.01% 3854
2021
Q4
Sell
-1
Closed 3257
2021
Q3
$0 Sell
1
-1
-50% -$7 ﹤0.01% 3879
2021
Q2
$0 Hold
2
﹤0.01% 3878
2021
Q1
$0 Buy
+2
New +$17 ﹤0.01% 3669

Other funds holding MBOT

Harbour Investments's MBOT Position: Q2 2026 in Review

Harbour Investments increased its Microbot Medical (MBOT) stake by 6,500% in Q2 2026, buying an estimated $133 and bringing the position to 66 shares worth $129. The position accounts for ﹤0.01% of the portfolio, ranked #4587.

Harbour Investments first reported a position in MBOT in Q1 2021 and has held it in 6 quarters since. 71 funds tracked by Wall St. Rank hold MBOT as of Q2 2026.

  • Harbour Investments held 66 shares of Microbot Medical worth $129 as of Q2 2026.
  • Harbour Investments bought 65 Microbot Medical shares in Q2 2026, an estimated $133.
  • Microbot Medical made up ﹤0.01% of Harbour Investments's portfolio in Q2 2026, its #4587 holding.
  • Harbour Investments first reported a position in Microbot Medical in Q1 2021 and has held it in 6 quarters since.
  • 71 funds tracked by Wall St. Rank held Microbot Medical as of Q2 2026.

Based on Harbour Investments's 13F filing for Q2 2026, filed 12 Aug 2026.